Copyright Reports & Markets. All rights reserved.

Global Point-of-care Testing (POCT) for Substance Abuse Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Based on Colloidal Gold
    • 1.3.3 Based on Fluorescence Immunochromatography
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic Center
    • 1.4.4 Road Traffic Safety
    • 1.4.5 Military
    • 1.4.6 Others
  • 1.5 Global Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecast
    • 1.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (2021-2032)
    • 1.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.1.4 Roche Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Danaher
    • 2.2.1 Danaher Details
    • 2.2.2 Danaher Major Business
    • 2.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.2.4 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Danaher Recent Developments/Updates
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.3.4 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Recent Developments/Updates
  • 2.4 Siemens
    • 2.4.1 Siemens Details
    • 2.4.2 Siemens Major Business
    • 2.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.4.4 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Siemens Recent Developments/Updates
  • 2.5 Beijing Hotgen Biotech
    • 2.5.1 Beijing Hotgen Biotech Details
    • 2.5.2 Beijing Hotgen Biotech Major Business
    • 2.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.5.4 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Beijing Hotgen Biotech Recent Developments/Updates
  • 2.6 Hangzhou Biotest Biotech CO.,LTD
    • 2.6.1 Hangzhou Biotest Biotech CO.,LTD Details
    • 2.6.2 Hangzhou Biotest Biotech CO.,LTD Major Business
    • 2.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.6.4 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
  • 2.7 Assure Tech
    • 2.7.1 Assure Tech Details
    • 2.7.2 Assure Tech Major Business
    • 2.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.7.4 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Assure Tech Recent Developments/Updates
  • 2.8 Orient Gene
    • 2.8.1 Orient Gene Details
    • 2.8.2 Orient Gene Major Business
    • 2.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.8.4 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Orient Gene Recent Developments/Updates
  • 2.9 Thermo Fisher
    • 2.9.1 Thermo Fisher Details
    • 2.9.2 Thermo Fisher Major Business
    • 2.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.9.4 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Thermo Fisher Recent Developments/Updates
  • 2.10 Guangzhou Wondfo Biotech Co.,Ltd.
    • 2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
    • 2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
    • 2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
  • 2.11 Hangzhou Alltest Biotech Co.,Ltd.
    • 2.11.1 Hangzhou Alltest Biotech Co.,Ltd. Details
    • 2.11.2 Hangzhou Alltest Biotech Co.,Ltd. Major Business
    • 2.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.11.4 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
  • 2.12 Beckman Coulter
    • 2.12.1 Beckman Coulter Details
    • 2.12.2 Beckman Coulter Major Business
    • 2.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.12.4 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Beckman Coulter Recent Developments/Updates
  • 2.13 Bio-Rad
    • 2.13.1 Bio-Rad Details
    • 2.13.2 Bio-Rad Major Business
    • 2.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.13.4 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bio-Rad Recent Developments/Updates
  • 2.14 BioMerieux
    • 2.14.1 BioMerieux Details
    • 2.14.2 BioMerieux Major Business
    • 2.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
    • 2.14.4 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 BioMerieux Recent Developments/Updates

3 Competitive Environment: Point-of-care Testing (POCT) for Substance Abuse by Manufacturer

  • 3.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Manufacturer (2021-2026)
  • 3.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2025
  • 3.5 Point-of-care Testing (POCT) for Substance Abuse Market: Overall Company Footprint Analysis
    • 3.5.1 Point-of-care Testing (POCT) for Substance Abuse Market: Region Footprint
    • 3.5.2 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
    • 3.5.3 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
    • 4.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2021-2032)
    • 4.1.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2021-2032)
  • 4.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021-2032)
  • 4.3 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021-2032)
  • 4.5 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 5.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2021-2032)
  • 5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 6.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2021-2032)
  • 6.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 7.2 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 7.3 North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
    • 7.3.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 8.2 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 8.3 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
    • 8.3.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
    • 9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 10.2 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 10.3 South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
    • 10.3.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
    • 11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
  • 12.2 Point-of-care Testing (POCT) for Substance Abuse Market Restraints
  • 12.3 Point-of-care Testing (POCT) for Substance Abuse Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Point-of-care Testing (POCT) for Substance Abuse and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Substance Abuse
  • 13.3 Point-of-care Testing (POCT) for Substance Abuse Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
  • 14.3 Point-of-care Testing (POCT) for Substance Abuse Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Substance Abuse market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Substance Abuse market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Substance Abuse market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Point-of-care Testing (POCT) for Substance Abuse
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Point-of-care Testing (POCT) for Substance Abuse market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene, Thermo Fisher, Guangzhou Wondfo Biotech Co.,Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Point-of-care Testing (POCT) for Substance Abuse market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Based on Colloidal Gold
    Based on Fluorescence Immunochromatography
    Market segment by Application
    Hospital
    Diagnostic Center
    Road Traffic Safety
    Military
    Others
    Major players covered
    Roche
    Danaher
    Abbott
    Siemens
    Beijing Hotgen Biotech
    Hangzhou Biotest Biotech CO.,LTD
    Assure Tech
    Orient Gene
    Thermo Fisher
    Guangzhou Wondfo Biotech Co.,Ltd.
    Hangzhou Alltest Biotech Co.,Ltd.
    Beckman Coulter
    Bio-Rad
    BioMerieux
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Point-of-care Testing (POCT) for Substance Abuse product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Substance Abuse, with price, sales quantity, revenue, and global market share of Point-of-care Testing (POCT) for Substance Abuse from 2021 to 2026.
    Chapter 3, the Point-of-care Testing (POCT) for Substance Abuse competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Point-of-care Testing (POCT) for Substance Abuse breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Point-of-care Testing (POCT) for Substance Abuse market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Substance Abuse.
    Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Substance Abuse sales channel, distributors, customers, research findings and conclusion.

    Buy now